Submitted by Anonymous (not verified) on 12 November 2025 - 16:00
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 23, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 23, Status: Authorised